Real-World test: can newer blood thinners safely prevent clots in autoimmune patients?
NCT ID NCT07372170
Summary
This study aims to see if newer, easier-to-use blood thinners (DOACs) work as well and are as safe as the older standard medication (warfarin) for preventing repeat blood clots. It will follow 600 adults with a specific autoimmune clotting disorder who have already had a clot and are taking one of these medications as part of their normal care. The goal is to gather real-world evidence to help doctors choose the best long-term treatment to control this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME (APS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Hospital Universitario Infanta Leonor
RECRUITINGMadrid, Madrid, 28031, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Infanta Sofía
RECRUITINGMadrid, Madrid, Spain
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.